Water-soluble derivatives of 4-oxo-N-(4-hydroxyphenyl) retinamide: synthesis and biological activity-Reference-Cited by-同舟云学术

Water-soluble derivatives of 4-oxo-N-(4-hydroxyphenyl) retinamide: synthesis and biological activity

Published:2016-06-06 Issue:4 Volume:88 Page:608-614
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Musso Loana¹,Tiberio Paola²,Appierto Valentina²,Cincinelli Raffaella¹,Cavadini Elena²,Cleris Loredana²,Daidone Maria Grazia²,Dallavalle Sabrina¹

Affiliation:

1. Department of Food, Environmental and Nutritional Sciences; Division of Chemistry and Molecular Biology; Università degli Studi di Milano; Milano Italy

2. Department of Experimental Oncology and Molecular Medicine; Fondazione IRCCS - Istituto Nazionale dei Tumori; Milano Italy

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cbdd.12781/fullpdf

Reference18 articles.

1. Retinoid-induced apoptosis in normal and neoplastic tissues

2. Randomized Trial of Fenretinide to Prevent Second Breast Malignancy in Women With Early Breast Cancer

3. Randomized trial of fenretinide (4‐HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: Long‐term results

4. Effects of topical treatment with fenretinide (4-HPR) and plasma vitamin A levels in patients with actinic keratoses

5. Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Encapsulation of 4-oxo-N-(4-hydroxyphenyl) retinamide in human serum albumin nanoparticles promotes EZH2 degradation in preclinical neuroblastoma models;Nanoscale;2024

2. Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia;European Journal of Medicinal Chemistry;2021-08

3. Sodium 4-Carboxymethoxyimino-(4-HPR) a Novel Water-Soluble Derivative of 4-Oxo-4-HPR Endowed with In Vivo Anticancer Activity on Solid Tumors;Frontiers in Pharmacology;2017-04-26